Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives

Total article views   HTML views PDF downloads Totals
10,051 Dovepress* 7,446+ 1,342 8,788
PubMed Central* 2,605 448 3,053
Totals 10,051 1,790 11,841
*Since 5 March 2021

View citations on PubMed Central and Google Scholar